Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Denosumab in Reversing Periprosthetic Bone Loss Following Hip Replacement

NCT02444585 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02444585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02444585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Denosumab in Reversing Periprosthetic Bone Loss Following Hip Replacement
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Withdrawn
Start date
February 28, 2017
Completion date
December 31, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, hip